ANISH BHATNAGAR (President and CEO) sold 2.9% of their position (21.63K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $1.07M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/3/2024ACC: 0001415889-24-024658
DirectorOfficer· President and CEO
Since Jan 2019
-21.63K
Net shares
Net seller
$1.07M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
21.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−19.41K
Price / share
$49.34
Trade value
$957.76K
% of position
2.6%
10/1/2024
741.19K→721.77K
Common Stock
Direct
Shares
−2.22K
Price / share
$50.25
Trade value
$111.55K
% of position
0.3%
10/1/2024
721.77K→719.55K
Total
Net shares
−21.63K
Net value
-$1.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2024 | S · Sale | −19.41K | $49.34 | $957.76K | 2.6% | 741.19K | 721.77K |
| Common Stock Direct | 10/1/2024 | S · Sale | −2.22K | $50.25 | $111.55K | 0.3% | 721.77K | 719.55K |
| Total | −21.63K | -$1.07M | ||||||
Derivative Transactions0
No derivative transactions reported